News Daily News Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM L.A. McKeown April 15, 2025
News Daily News New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Yael L. Maxwell May 08, 2024
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022
News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term Shelley Wood April 03, 2022
News Daily News Preemptive Alcohol Septal Ablation May Help Prevent LVOT Obstruction in TMVR Yael L. Maxwell July 11, 2019
News Daily News Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI Michael O'Riordan February 20, 2018
Presentation TCT 2014 Interventional Perspective: Not Surgery of Course! Presenter: Carey D. Kimmelstiel September 16, 2014
Presentation ACVS 2012 Interventional Treatment of HOCM: Overview of Techniques and Results Presenter: Rajeev Lochan August 03, 2012